Effectiveness of mepolizumab in severe asthma in Japan: A real-world study using claims data

被引：4
|
作者：
Nagase, Hiroyuki [1 ]
Tamaoki, Jun [2 ]
Suzuki, Takeo [3 ]
Nezu, Yasuko [2 ]
Katsumata, Masayuki [3 ]
Komatsubara, Masaki [2 ]
Mu, George [4 ]
Yang, Shibing [4 ]
Cole, Ashley L. [4 ]
Alfonso-Cristancho, Rafael [4 ]
机构：
[1] Teikyo Univ, Sch Med, Dept Med, Div Resp Med & Allergol, Tokyo, Japan
[2] GSK, Resp Med Affairs & Dev, Tokyo, Japan
[3] GSK, Value Evidence & Outcomes, Tokyo, Japan
[4] GSK, Value Evidence & Outcomes, 1250 S Collegeville Rd, Collegeville, PA 19426 USA
来源：
CLINICAL AND TRANSLATIONAL ALLERGY | 2021年 / 11卷 / 08期
关键词：
D O I：
10.1002/clt2.12063
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [11] Real-world Effectiveness of Mepolizumab in the Treatment of Asthma in Japan: A Multicenter Retrospective Observational Study: J-Real-Mepo
    Nagase, H.
    Kobayashi, K.
    Suzukawa, M.
    Masaki, K.
    Miyata, Y.
    Tsuji, M.
    Terada, J.
    Komatsuzaki, K.
    Sugihara, N.
    Kihara, T.
    Ishikawa, N.
    Koya, T.
    Miyazaki, Y.
    Hojo, M.
    Tagaya, E.
    Tanaka, A.
    Harada, N.
    Fukunaga, K.
    Gon, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [12] Predicting real-world response to mepolizumab in severe asthma using machine learning
    Usuba, Koyo
    Zhang, Lingjiao
    Liu, Xinyang
    Han, Tim
    Nightingale, Natalie
    Tehrani, Ali
    Zhang, Shiyuan
    Howarth, Peter
    Alfonso-Cristancho, Rafael
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [13] MEPOLIZUMAB REDUCES EXACERBATIONS IN SEVERE EOSINOPHILIC ASTHMA: A REAL-WORLD STUDY.
    Harvey, E.
    Langton, D.
    Farah, C.
    Gillman, A.
    Harrington, J.
    Hew, M.
    Katelaris, C.
    Kritikos, V
    Radhakrishna, N.
    Stevens, S.
    Gibson, P.
    RESPIROLOGY, 2020, 25 : 105 - 105
  • [14] Reduction in asthma exacerbation rate after mepolizumab treatment initiation in patients with severe asthma: A real-world database study in Japan
    Nagase, Hiroyuki
    Tamaoki, Jun
    Suzuki, Takeo
    Nezu, Yasuko
    Akiyama, Shoko
    Cole, Ashley L.
    Yang, Shibing
    Mu, George
    Katsumata, Masayuki
    Komatsubara, Masaki
    Alfonso-Cristancho, Rafael
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2022, 75
  • [15] Real-world effectiveness of dupilumab vs benralizumab and vs mepolizumab in severe asthma: The EU-ADVANTAGE study
    Virchow, J. Christian
    Canonica, Giorgio W.
    Bourdin, Arnaud
    Jacob-Nara, Juby
    Borsos, Kinga
    Stanford, Richard H.
    Pandit-Abid, Nami
    Wang, Zhixiao
    Soliman, Mena
    Huynh, Lynn
    Kalia, Sarah
    Cheng, Wendy
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [16] Systematic Review of Real-World Effectiveness and Safety Studies of Mepolizumab in Treating Severe Eosinophilic Asthma
    Israel, E.
    Canonica, G. W.
    Brusselle, G.
    Yang, S.
    Howarth, P.
    Martin, A.
    Koufopoulou, M.
    Smith, S. G.
    Cristancho, R. Alfonso
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [17] COMPARISON OF REAL-WORLD SAFETY AND EFFECTIVENESS OF MEPOLIZUMAB AND BENRALIZUMAB IN THE MANAGEMENT OF SEVERE ASTHMA: A SYSTEMATIC REVIEW
    Bhavanasai, S.
    Vullengala, N.
    Yarramsetti, P.
    Jan, R.
    Kaur, G.
    Udhayasri, R.
    Sodhi, B.
    Gomes, A.
    Dang, A.
    Dang, D.
    Vallish, B. N.
    VALUE IN HEALTH, 2023, 26 (12) : S523 - S523
  • [18] Real-world Effectiveness of Mepolizumab in Severe Eosinophilic Asthma: A Systematic Review and Meta-analysis
    Li, Hongwen
    Zhang, Qing
    Wang, Jingru
    Gao, Shengnan
    Li, Chunxiao
    Wang, Jianxin
    Zhang, Shuhua
    Lin, Jiangtao
    CLINICAL THERAPEUTICS, 2021, 43 (06) : E192 - E208
  • [19] Real-world outcomes of mepolizumab for the treatment of severe eosinophilic asthma in Canada: an observational study
    Chapman, Kenneth R.
    Cogger, Kathryn
    Arthurs, Erin
    LaForty, Callahan
    Golden, Shane
    Millson, Bradley
    Usuba, Koyo
    Licskai, Christopher
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2024, 20 (01):
  • [20] Real-world outcomes of mepolizumab for the treatment of severe eosinophilic asthma in Canada: an observational study
    Kenneth R. Chapman
    Kathryn Cogger
    Erin Arthurs
    Callahan LaForty
    Shane Golden
    Bradley Millson
    Koyo Usuba
    Christopher Licskai
    Allergy, Asthma & Clinical Immunology, 20
12345